Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
about
Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis CKASL clinical practice guidelines: management of hepatitis CHepatitis C genotype 4: The past, present, and futureClinical applications of transient elastographyNoninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.Shear wave elastography for evaluation of liver fibrosisLiver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral loadA secreted form of the asialoglycoprotein receptor, sH2a, as a novel potential noninvasive marker for liver fibrosisT2 relaxation time is related to liver fibrosis severity.Point shear wave elastography method for assessing liver stiffnessLiver elastography, comments on EFSUMB elastography guidelines 2013.Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study.An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesAn update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.Effect of alcohol consumption on liver stiffness measured by transient elastography.SASLT practice guidelines: management of hepatitis C virus infection.Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients.SASLT practice guidelines for the management of hepatitis B virus.Management of nonresponsive hepatitis C.2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.Optimal treatment with boceprevir for chronic HCV infection.Advances in the management of hepatitis C.Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.Non-invasive assessment of liver fibrosis and prognosis.Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.Screening and diagnosis of HBV in low-income and middle-income countries.Dynamic Changes in Liver Stiffness Measured by Transient Elastography Predict Clinical Outcomes Among Patients With Chronic Hepatitis B.Efficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection.Stepwise Application of FIB-4, Red cell distribution width-Platelet Ratio and APRI for Compensated Hepatitis B Fibrosis Detection.Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.Non-invasive assessment of liver fibrosis using acoustic structure quantification: comparison with transient elastography in chronic viral hepatitis.Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C.Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis.A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy.
P2860
Q24188065-1D2696AB-DB29-4775-9606-B2AA7EADF29EQ26752471-86DB46FF-F96A-400C-B202-9ADFD82F7912Q26775815-27A1DF89-B69E-4AC4-A10B-575E917218FCQ26828052-4DF4B86D-ABEF-42C6-8D16-A0E9A5A3EF76Q26853160-AD81F291-CC63-4DBF-A418-494CD7DF1FEEQ27022470-6519D6AE-A7D3-4B0C-B315-411209618D56Q28479262-0A4A46AF-FB3F-4984-9109-3E04C10570B7Q28742875-F0FFB636-4250-4643-AFA7-BA1C48F04F57Q30383680-12855DA3-D3CF-40D4-9672-86886703F97DQ30439553-6E31D0E1-3A2D-4E8E-ABC8-485BC8071C93Q30448132-076F0594-8662-4D65-A576-E1305C1D9DB0Q30449245-2F8FA684-33D8-4959-AE25-090AD8D60EC3Q30453975-FFE8E671-43CB-4B84-98F7-19FDDAB9ED81Q34359330-4A166D15-00E4-48C8-940F-EDD0D65A46AFQ34561257-F2F8BE74-710D-4CAF-B912-2E12ED9397A2Q35100139-67E795B5-1665-4F13-B1B1-37E91B6AF458Q36084923-D1599493-463F-4951-8646-7B780697ABCDQ36572495-44D78B1B-0CF5-4C90-BBE4-043F59104F38Q37019765-FD622FD8-BE3A-448C-A766-50850CACC1EEQ37571093-55B3C6EF-C7AF-4488-8B4E-8FE46F6E1BC4Q37634822-59774D55-230A-4689-BB7C-8AFCCD3334F3Q37727164-970B4FCA-7B6C-40EF-9077-044FEACFAEE5Q37972754-8FDB2A09-0DFB-46A0-96E5-112186467CEEQ38071383-3B9A9010-1D31-4B5C-A97A-A688F200D8AAQ38170564-D3FD24D4-AC23-4A54-9956-756403A306D1Q38297230-0672BF05-9C5D-4656-B2CC-BC7963795C20Q38588078-2475FC73-5DC1-483F-925A-E5C53FB17D7AQ38914346-C21388A1-381D-4892-8030-1211722D8722Q38953790-ADEB1876-112E-43F2-BD18-0BA90F58FB14Q39134237-4F51E0F4-FAAD-4E80-80E8-5F9BD49BCCB5Q40088333-59A45634-7271-46D6-9B6D-ECA242F71744Q40223838-4CF91969-1FBF-4B4B-8D20-A024B5A5243BQ40784890-AC45FCFE-C5F2-4224-A303-86DD6710C8CFQ40790849-9380FB32-99E7-4F3A-9104-0791D936160EQ40915287-5F7E05DA-A3A0-473E-902F-71A348D0E1BCQ41711121-A1FAA0E8-0022-4A61-92C4-52EF2E3A78F7Q42198890-9D2CBB90-AF70-43D7-B545-365771DA1EEFQ42251200-961CB14D-DD3D-48F7-8AD3-663FB5E321C1Q42263583-CF07C42E-FC06-4B7F-A5E5-B06A01CBB12BQ42990080-C54B7629-4441-423C-8C73-5F616E893078
P2860
Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transient elastography and oth ...... patients with viral hepatitis.
@en
Transient elastography and oth ...... patients with viral hepatitis.
@nl
type
label
Transient elastography and oth ...... patients with viral hepatitis.
@en
Transient elastography and oth ...... patients with viral hepatitis.
@nl
prefLabel
Transient elastography and oth ...... patients with viral hepatitis.
@en
Transient elastography and oth ...... patients with viral hepatitis.
@nl
P2860
P1476
Transient elastography and oth ...... patients with viral hepatitis.
@en
P2093
Laurent Castera
P2860
P304
P356
10.1111/J.1365-2893.2009.01087.X
P577
2009-02-25T00:00:00Z